{"transactions":[{"id":732341,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36863,"kind":"person","name":"Loy Spike","position":1,"cik":"0001920549","reported_name":"Loy Spike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2026-06-18T22:45:05.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":22195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 22,195 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 17, 2027 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":22195,"derivative":{"exercise_price":19.19,"expiration_date":"2036-06-17","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":22195},"source":{"system":"sec-edgar","filing":"0001213900-26-070257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920549/000121390026070257/ownership.xml","form_type":"4"}},{"id":1118243,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36863,"kind":"person","name":"Loy Spike","position":1,"cik":"0001920549","reported_name":"Loy Spike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2025-06-09T13:07:53.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6682,"derivative":{"exercise_price":48.83,"expiration_date":"2035-06-05","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":6682},"source":{"system":"sec-edgar","filing":"0001213900-25-052368","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920549/000121390025052368/ownership.xml","form_type":"4"}},{"id":1487176,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36863,"kind":"person","name":"Loy Spike","position":1,"cik":"0001920549","reported_name":"Loy Spike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2024-06-07T20:58:52.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 7,688 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 6, 2025, (ii) the date of the Issuer's next annual general meeting of shareholders and (iii) the date of a Change in Control (as defined in the MoonLake Immunotherapeutics 2022 Equity Incentive Plan) of the Issuer, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":7688,"derivative":{"exercise_price":42.44,"expiration_date":"2034-06-06","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":7688},"source":{"system":"sec-edgar","filing":"0001213900-24-050824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920549/000121390024050824/ownership.xml","form_type":"4"}},{"id":1859157,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":36863,"kind":"person","name":"Loy Spike","position":1,"cik":"0001920549","reported_name":"Loy Spike","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2023-06-12T20:52:43.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":11297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":11297,"derivative":{"exercise_price":29.18,"expiration_date":"2033-06-08","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":11297},"source":{"system":"sec-edgar","filing":"0001213900-23-048200","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920549/000121390023048200/ownership.xml","form_type":"4"}}]}